The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of the results are good news, and half of the stocks have a price-earnings ratio of less than 30 times. Rongyi Finance and Economics

Key Data Concepts:   

? These are the company names, stock quotes, topics, and entities related to this data.

000028 000513 000661 000925 002014 002581 300122 300485 300601 300713 300841 Beijing Science Sun Pharmaceutical Beijing Wantai Biological Pharmacy Enterprise Changchun High & New Technology Industry Chengdu Kanghua Biological Products China National Accord Medicines Corporation China National Medicines Corporation Chongqing Zhifei Biological Products Huangshan Novel Joincare Pharmaceutical Group Industry Livzon Pharmaceutical Group Shandong Sinobioway Biomedicine Shanghai Fosun Pharmaceutical Shanghai Shyndec Pharmaceutical Shenzhen Kangtai Biological Products Shenzhenrease Technology Unittec Accounting, Audit Earnings Annual, Special Corporate Meeting Annual Report Research, Development Health, Beauty Product Pharmaceutical Construction, Property Design, Engineering Manufacturing, Engineering Securities Stocks Epidemic Vaccines Workplace Health, Safety House, Home Government Biology Economics Technology, Engineering Economy, Business, Finance Health

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Home » News » The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of the results are good news, and half of the stocks have a price-earnings ratio of less than 30 times. Rongyi Finance and Economics